ENLIL THERAPEUTICS
ENLIL THERAPEUTICS
Founded:
2017-11-29
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
LifeShip
Space and Biotech
Founder
More informations about "Enlil Therapeutics"
Enlil Therapeutics - Three Lakes Foundation 2/3
Enlil Therapeutics. ORGANIZATION. Enlil Therapeutics is a start-up company founded to discover cures for telomere-related diseases. Currently, the company is focused on identifying …See details»
The PRECISIONS Study | Three Lakes Foundation
ORGANIZATION. Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) is a comprehensive, multicenter, and multi-investigator study that is advancing the approach to evaluating and managing patients with …See details»
Enlil Therapeutics Inc · 36407 Sereno Cmn, Fremont, CA 94536-2710
ENLIL THERAPEUTICS INC is an entity in Fremont, California registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was …See details»
Enlil Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Enlil Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen …See details»
Enlil Therapeutics - Crunchbase
Organization. Enlil Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. ...See details»
Alexey Bazarov - Enlil Therapeutics - LinkedIn
Enlil Therapeutics San Francisco Bay Area -San Francisco Bay Area -San Francisco Bay Area -----Education Yale University 1993 - 1999. 1993 - 1995. 1990 - 1993. Activities and Societies: Golden Key ...See details»
Enlil Therapeutics Inc in Fremont, CA - (650) 906-0195 - Profile
Enlil Therapeutics Inc is in the Business Activities At Non-Commercial Site business. View competitors, revenue, employees, website and phone number. The Most Advanced Company …See details»
Three Lakes Consortium for PF (TLC4PF)
Enlil Therapeutics . Three Lakes Foundation has provided funding to support Enlil Therapeutics in its quest to identify compounds that activate telomerase. Read More. B4PF: Understanding …See details»
Enlil Company Profile 2024: Valuation, Funding & Investors
Enlil General Information Description. Developer of cloud-based enterprise resource planning software intended for medical device companies to get to market faster. The company's …See details»
In the quest for new medicines, developers seek to …
Jan 7, 2024 Developing and testing a drug candidate can take years of effort and billions of dollars of investment. Any shortcut that AI can offer could be a game changerSee details»
Enliven Therapeutics - Crunchbase Company Profile & Funding
Enliven Therapeutics may be growing as indicated by a recent $90 million private placement financing, which suggests an influx of capital to support its operations and research. …See details»
EGCG for IPF | Three Lakes Foundation
ORGANIZATION. EGCG was discovered as an antifibrotic in pre-clinical in vivo studies with a mechanism of action blocking collagen accumulation that was published in 2017. A pilot study …See details»
KBI Biopharma to Lead Development and Manufacturing of Alanis ...
DURHAM, N.C., December 03, 2024--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces …See details»
Delix Therapeutics Announces Dosing of First Patient in Phase 1b ...
11 hours ago BEDFORD, Mass., December 04, 2024--Delix Therapeutics, a clinical-stage neuroscience company pioneering novel neuroplasticity-promoting treatments for psychiatric …See details»
Enlil - Crunchbase Company Profile & Funding
Enlil is a SaaS service that enables medical device manufacturers to monitor the data needed to accomplish significant goals. Provides a compliant cloud solution that lets users monitor all …See details»
PTC Therapeutics signs up to $2.9 billion licensing deal with ... - MSN
(Reuters) - PTC Therapeutics has signed an up to $2.9 billion licensing deal with Novartis AG for the U.S. company's experimental drug for a rare neurological disorder, sending its shares up …See details»
An Atlas of IPF Lung Cells | Three Lakes Foundation
ORGANIZATION. This research study was designed to identify the cellular changes that occur in the human lung cells as fibrosis develops. Using a single-cell RNA sequencing technique, the …See details»
FDA approves first cell therapy in landmark achievement for ...
Apr 2, 2024 OICR President and Scientific Director Dr. Laszlo Radvanyi reflects on the potential impact of a novel drug for metastatic melanoma, and his important role in the drug’s …See details»
The Impact of Antimicrobial Therapy in IPF
ORGANIZATION. Clean-UP IPF was the first pragmatic trial in IPF that studied whether antimicrobial therapy would improve hospitalization or decrease death. Pragmatic trials are …See details»